Exelixis Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
31,338.00
25,111.00
37,172.00
191,454.00
452,677.00
845,742
Cost of Goods Sold (COGS) incl. D&A
4,265.00
4,434.00
3,895.00
6,552.00
15,066.00
26,348
Gross Income
27,073.00
20,677.00
33,277.00
184,902.00
437,611.00
819,394
SG&A Expense
226,574.00
237,539.00
137,056.00
220,883.00
267,993.00
388,623
EBIT
199,501.00
216,862.00
-
-
169,618.00
430,771
Unusual Expense
1,231.00
5,796.00
17,093.00
6,044.00
9,747.00
8,084
Non Operating Income/Expense
-
2,541.00
137.00
2,285.00
2,502.00
397
Interest Expense
45,347.00
48,607.00
40,680.00
33,060.00
8,679.00
-
Pretax Income
244,856.00
268,724.00
161,689.00
70,222.00
158,577.00
452,092
Income Tax
96.00
182.00
55.00
-
4,350.00
237,978
Consolidated Net Income
244,760.00
268,542.00
161,744.00
70,222.00
153,860.00
690,070
Net Income
244,760.00
268,542.00
161,744.00
70,222.00
153,860.00
690,070
Net Income After Extraordinaries
244,760.00
268,542.00
161,744.00
70,222.00
153,860.00
690,070
Net Income Available to Common
244,760.00
268,542.00
161,744.00
70,222.00
153,860.00
690,070
EPS (Basic)
1.33
1.38
0.77
0.28
0.49
2.21
Basic Shares Outstanding
184,062.00
194,299.00
209,227.00
250,531.00
293,588.00
297,892
EPS (Diluted)
1.33
1.38
0.77
0.28
0.49
2.21
Diluted Shares Outstanding
184,062.00
194,299.00
209,227.00
250,531.00
312,003.00
312,803
EBITDA
196,354.00
214,471.00
102,373.00
34,979.00
170,805.00
438,540
Non-Operating Interest Income
1,223.00
-
-
2,578.00
4,883.00
12,840
Other After Tax Income (Expense)
-
-
-
-
367.00
-

About Exelixis

View Profile
Address
1851 Harbor Bay
Parkway Alameda California 94502
United States
Employees -
Website http://www.exelixis.com
Updated 07/08/2019
Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S.